List of Figures
Figure 1: Clinical Trial Recruitment in CVD, Global, Ongoing Trials by Therapeutic Area, 2005-2010
Figure 2: Clinical Trial Recruitment in CVD, Global, Number of Patients Recruited for Major Indications, 2000-2009
Figure 3: Clinical Trial Recruitment in CVD, Global, Ongoing Trials by Therapeutic Area, 2005-2010
Figure 4: Clinical Trial Recruitment in CVD, Asia, Ongoing Trials by Therapeutic Area, 2005-2010
Figure 5: Clinical Trial Recruitment in CVD, Europe, Ongoing Trials by Therapeutic Area, 2005-2010
Figure 6: Clinical Trial Recruitment in CVD, Middle East, Ongoing Trials by Therapeutic Area, 2005-2010
Figure 7: Clinical Trial Recruitment in CVD, South and Central America, Ongoing Trials by Therapeutic Area, 2005-2010
Figure 8: Clinical Trial Recruitment in CVD, North America, Ongoing Trials by Therapeutic Area, 2005-2010
Figure 9: Clinical Trial Recruitment in CVD, Rest of the World, Ongoing Trials by Therapeutic Area, 2005-2010
Figure 10: Clinical Trial Recruitment in CVD, Global, Clinical Trials by Major Pharmaceutical Companies, 2005-2010
Figure 11: Clinical Trial Recruitment in CVD, Global, Number of Clinical Trials for Major Indications, 2000-2009
Figure 12: Clinical Trial Recruitment in CVD, Global, Number of Patients Recruited for Major Indications, 2000-2009
Figure 13: Clinical Trial Recruitment in CVD, Hypertension, Total Number of Clinical Trials by Phase, 2000–2009
Figure 14: Clinical Trial Recruitment in CVD, Hypertension, Total Number of Clinical Trials by Major Sponsors, 2000–2009
Figure 15: Clinical Trial Recruitment in CVD, Hypertension, Total Number of Clinical Trials by Geography, 2000–2009
Figure 16: Clinical Trial Recruitment in CVD, Hypertension, Total Number of Clinical Trials per Year, 2000–2009
Figure 17: Clinical Trial Recruitment in CVD, Hypertension, Brazil, Prevalence Population, million, 2010–2017
Figure 18: Clinical Trial Recruitment in CVD, Hypertension, India, Prevalence Population, million 2010–2017
Figure 19: Clinical Trial Recruitment in CVD, Hypertension, China, Prevalence Population, million 2010–2017
Figure 20: Clinical Trial Recruitment in CVD, Hypertension, Total Number of Patients Recruited by Phase, 2000–2009
Figure 21: Clinical Trial Recruitment in CVD, Hypertension, Total Number of Patients Recruited by Major Sponsors, 2000–2009
Figure 22: Clinical Trial Recruitment in CVD, Hypertension, Total Number of Patients Recruited by Geography, 2000–2009
Figure 23: Clinical Trial Recruitment in CVD, Hypertension, Total Number of Patients Recruited per Year, 2000–2009
Figure 24: Clinical Trial Recruitment in CVD, Hypertension, Average Number of Patients Recruited per Trial by Stage of Development, 2000–2009
Figure 25: Clinical Trial Recruitment in CVD, Hypertension, Average Number of Patients Recruited per Trial per Year, 2000–2009
Figure 26: Clinical Trial Recruitment in CVD, Atherosclerosis, Total Number of Clinical Trials, 2000–2009
Figure 27: Clinical Trial Recruitment in CVD, Atherosclerosis, Total Number of Clinical Trials by Major Sponsors, 2000–2009
Figure 28: Clinical Trial Recruitment in CVD, Atherosclerosis, Total Number of Clinical Trials by Geography, 2000–2009
Figure 29: Clinical Trial Recruitment in CVD, Atherosclerosis, Total Number of Clinical Trials per Year, 2000–2009
Figure 30: Clinical Trial Recruitment in CVD, Atherosclerosis, Brazil, Prevalence Population, million, 2010–2017
Figure 31: Clinical Trial Recruitment in CVD, Atherosclerosis, India, Prevalence Population, million, 2010–2017
Figure 32: Clinical Trial Recruitment in CVD, Atherosclerosis, China, Prevalence Population, million, 2010–2017
Figure 33: Clinical Trial Recruitment in CVD, Atherosclerosis, Total Number of Patients Recruited by Phase, 2000–2009
Figure 34: Clinical Trial Recruitment in CVD, Atherosclerosis, Total Number of Patients Recruited by Major Sponsors, 2000–2009
Figure 35: Clinical Trial Recruitment in CVD, Atherosclerosis, Total Number of Patients Recruited by Geography, 2000–2009
Figure 36: Clinical Trial Recruitment in CVD, Atherosclerosis, Total Number of Patients Recruited per Year, 2000–2009
Figure 37: Clinical Trial Recruitment in CVD, Atherosclerosis, Average Number of Patients Recruited per Trial by Stage of Development, 2000–2009
Figure 38: Clinical Trial Recruitment in CVD, Atherosclerosis, Average Number of Patients Recruited per Trial per Year, 2000–2009
Figure 39: Clinical Trial Recruitment in CVD, Dyslipidemia, Total Number of Clinical Trials by Phase, 2000–2009
Figure 40: Clinical Trial Recruitment in CVD, Dyslipidemia, Total Number of Clinical Trials by Major Sponsors, 2000–2009
Figure 41: Clinical Trial Recruitment in CVD, Dyslipidemia, Total Number of Clinical Trials by Geography, 2000–2009
Figure 42: Clinical Trial Recruitment in CVD, Dyslipidemia, Total Number of Clinical Trials per Year, 2000–2009
Figure 43: Clinical Trial Recruitment in CVD, Dyslipidemia, Brazil, Prevalence Population, million, 2010–2017
Figure 44: Clinical Trial Recruitment in CVD, Dyslipidemia, India, Prevalence Population, million, 2010–2017
Figure 45: Clinical Trial Recruitment in CVD, Dyslipidemia, China, Prevalence Population, million, 2010–2017
Figure 46: Clinical Trial Recruitment in CVD, Dyslipidemia, Total Number of Patients Recruited by Phase, 2000–2009
Figure 47: Clinical Trial Recruitment in CVD, Dyslipidemia, Total Number of Patients Recruited by Major Sponsors, 2000–2009
Figure 48: Clinical Trial Recruitment in CVD, Dyslipidemia, Total Number of Patients Recruited by Geography, 2000–2009
Figure 49: Clinical Trial Recruitment in CVD, Dyslipidemia, Total Number of Patients Recruited per Year, 2000–2009
Figure 50: Clinical Trial Recruitment in CVD, Dyslipidemia, Average Number of Patients Recruited per Trial by Stage of Development, 2000–2009
Figure 51: Clinical Trial Recruitment in CVD, Dyslipidemia, Average Number of Patients Recruited per Trial per Year, 2000–2009
Figure 52: Clinical Trial Recruitment in CVD, Atrial Fibrillation, Total Number of Clinical Trials by Phase, 2000–2009
Figure 53: Clinical Trial Recruitment in CVD, Atrial Fibrillation, Total Number of Clinical Trials by Major Sponsors, 2000–2009
Figure 54: Clinical Trial Recruitment in CVD, Atrial Fibrillation, Total Number of Clinical Trials by Geography, 2000–2009
Figure 55: Clinical Trial Recruitment in CVD, Atrial Fibrillation, Total Number of Clinical Trials per Year, 2000–2009
Figure 56: Clinical Trial Recruitment in CVD, Atrial Fibrillation, Brazil, Prevalence Population, million, 2010–2017
Figure 57: Clinical Trial Recruitment in CVD, Atrial Fibrillation, India, Prevalence Population, million, 2010–2017
Figure 58: Clinical Trial Recruitment in CVD, Atrial Fibrillation, China, Prevalence Population, million, 2010–2017
Figure 59: Clinical Trial Recruitment in CVD, Atrial Fibrillation, Total Number of Patients Recruited by Phase, 2000–2009
Figure 60: Clinical Trial Recruitment in CVD, Atrial Fibrillation, Total Number of Patients Recruited by Major Sponsors, 2000–2009
Figure 61: Clinical Trial Recruitment in CVD, Atrial Fibrillation, Total Number of Patients Recruited by Geography, 2000–2009
Figure 62: Clinical Trial Recruitment in CVD, Atrial Fibrillation, Total Number of Patients Recruited per Year, 2000–2009
Figure 63: Clinical Trial Recruitment in CVD, Atrial Fibrillation, Average Number of Patients Recruited per Trial by Stage of Development, 2000–2009
Figure 64: Clinical Trial Recruitment in CVD, Atrial Fibrillation, Average Number of Patients Recruited per Trial per Year, 2000–2009
Figure 65: Clinical Trial Recruitment in CVD, Venous Thromboembolism, Total Number of Clinical Trials by Phase, 2000–2009
Figure 66: Clinical Trial Recruitment in CVD, Venous Thromboembolism, Total Number of Clinical Trials by Major Sponsors, 2000–2009
Figure 67: Clinical Trial Recruitment in CVD, Venous Thromboembolism, Total Number of Clinical Trials by Geography, 2000–2009
Figure 68: Clinical Trial Recruitment in CVD, Venous Thromboembolism, Total Number of Clinical Trials per Year, 2000–2009
Figure 69: Clinical Trial Recruitment in CVD, Venous Thromboembolism, Brazil, Prevalence Population, thousands, 2010–2017
Figure 70: Clinical Trial Recruitment in CVD, Venous Thromboembolism, India, Prevalence Population, million, 2010–2017
Figure 71: Clinical Trial Recruitment in CVD, Venous Thromboembolism, China, Prevalence Population, million, 2010–2017
Figure 72: Clinical Trial Recruitment in CVD, Venous Thromboembolism, Total Number of Patients Recruited by Phase, 2000–2009
Figure 73: Clinical Trial Recruitment in CVD, Venous Thromboembolism, Total Number of Patients Recruited by Major Sponsors, 2000–2009
Figure 74: Clinical Trial Recruitment in CVD, Venous Thromboembolism, Total Number of Patients Recruited by Geography, 2000–2009
Figure 75: Clinical Trial Recruitment in CVD, Venous Thromboembolism, Total Number of Patients Recruited per Year, 2000–2009
Figure 76: Clinical Trial Recruitment in CVD, Venous Thromboembolism, Average Number of Patients Recruited per Trial by Stage of Development, 2000–2009
Figure 77: Clinical Trial Recruitment in CVD, Venous Thromboembolism, Average Number of Patients Recruited per Trial per Year, 2000–2009